Delivering Global Access to Life-Changing Gene Therapy for Children with Ultra-Rare Disease
Posted | April 27, 2026Study Overview In 2019, mdgroup partnered with Rocket Pharmaceuticals to support a Phase I/II clinical study investigating a gene therapy for pediatric patients with severe Leukocyte Adhesion Deficiency-I (LAD-I), an…














